Abstract

In C. elegans, ablation of germline stem cells (GSCs) extends lifespan, but also increases fat accumulation and alters lipid metabolism, raising the intriguing question of how these effects might be related. Here we show that a lack of GSCs results in a broad transcriptional reprogramming, in which the conserved detoxification regulator SKN-1/Nrf increases stress resistance, proteasome activity, and longevity. SKN-1 also activates diverse lipid metabolism genes and reduces fat storage, thereby alleviating the increased fat accumulation caused by GSC absence. Surprisingly, SKN-1 is activated by signals from this fat, which appears to derive from unconsumed yolk that was produced for reproduction. We conclude that SKN-1 plays a direct role in maintaining lipid homeostasis, in which it is activated by lipids. This SKN-1 function may explain the importance of mammalian Nrf proteins in fatty liver disease, and suggests that particular endogenous or dietary lipids might promote health through SKN-1/Nrf.

Article and author information

Author details

  1. Michael J Steinbaugh

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Sri Devi Narasimhan

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Stacey Robida-Stubbs

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Lorenza E Moronetti Mazzeo

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Jonathan M Dreyfuss

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. John M Hourihan

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Prashant Raghavan

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Theresa N Operaña

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Reza Esmaillie

    Research Division, Joslin Diabetes Center, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. T Keith Blackwell

    Research Division, Joslin Diabetes Center, Boston, United States
    For correspondence
    keith.blackwell@joslin.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.

Copyright

© 2015, Steinbaugh et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,246
    views
  • 183
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

Share this article

https://doi.org/10.7554/eLife.07836

Further reading

    1. Cancer Biology
    2. Cell Biology
    Salam Dabsan, Gali Zur ... Aeid Igbaria
    Research Article

    The endoplasmic reticulum (ER) is an essential sensing organelle responsible for the folding and secretion of almost one-third of eukaryotic cells' total proteins. However, environmental, chemical, and genetic insults often lead to protein misfolding in the ER, accumulating misfolded proteins, and causing ER stress. To solve this, several mechanisms were reported to relieve ER stress by decreasing the ER protein load. Recently, we reported a novel ER surveillance mechanism by which proteins from the secretory pathway are refluxed to the cytosol to relieve the ER of its content. The refluxed proteins gain new prosurvival functions in cancer cells, thereby increasing cancer cell fitness. We termed this phenomenon ER to CYtosol Signaling (or ‘ERCYS’). Here, we found that in mammalian cells, ERCYS is regulated by DNAJB12, DNAJB14, and the HSC70 cochaperone SGTA. Mechanistically, DNAJB12 and DNAJB14 bind HSC70 and SGTA - through their cytosolically localized J-domains to facilitate ER-protein reflux. DNAJB12 is necessary and sufficient to drive this phenomenon to increase AGR2 reflux and inhibit wt-p53 during ER stress. Mutations in DNAJB12/14 J-domain prevent the inhibitory interaction between AGR2-wt-p53. Thus, targeting the DNAJB12/14-HSC70/SGTA axis is a promising strategy to inhibit ERCYS and impair cancer cell fitness.

    1. Cancer Biology
    2. Cell Biology
    Brooke A Conti, Leo Novikov ... Mariano Oppikofer
    Research Article

    DNA base lesions, such as incorporation of uracil into DNA or base mismatches, can be mutagenic and toxic to replicating cells. To discover factors in repair of genomic uracil, we performed a CRISPR knockout screen in the presence of floxuridine, a chemotherapeutic agent that incorporates uracil and fluorouracil into DNA. We identified known factors, such as uracil DNA N-glycosylase (UNG), and unknown factors, such as the N6-adenosine methyltransferase, METTL3, as required to overcome floxuridine-driven cytotoxicity. Visualized with immunofluorescence, the product of METTL3 activity, N6-methyladenosine, formed nuclear foci in cells treated with floxuridine. The observed N6-methyladenosine was embedded in DNA, called 6mA, and these results were confirmed using an orthogonal approach, liquid chromatography coupled to tandem mass spectrometry. METTL3 and 6mA were required for repair of lesions driven by additional base-damaging agents, including raltitrexed, gemcitabine, and hydroxyurea. Our results establish a role for METTL3 and 6mA in promoting genome stability in mammalian cells, especially in response to base damage.